C
CVS
CVS agreed to pay $3.8 million to settle claims it falsely advertised its lidocaine products as 'maximum strength.' No proof of purchase is required to file a claim.
ClosedUnited States-wideClaim status: Closed on November 20, 2023Payout: Varies with proof of purchase; $13.50 without proof of purchaseNo longer claimable
About this settlement
Claims relate to CVS marketing lidocaine products as 'maximum strength' when they allegedly were not.
This settlement resolves claims that CVS falsely advertised its lidocaine patches, creams, roll-ons, and sprays as 'maximum strength.' Eligible consumers may receive compensation, with higher payouts available for those who provide proof of purchase.
Who qualifies
- Consumers who purchased CVS-branded lidocaine patches, creams, roll-ons, or sprays marketed as 'maximum strength.'
- Purchases of eligible SKUs including 376649, 405343, 977934, and others listed in the settlement details.
Varies with proof of purchase; $13.50 without proof of purchase
Claim status: Closed on November 20, 2023